{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:55Z","timestamp":1787020135790,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Support Program of China","award":["2017YFC1307600"],"award-info":[{"award-number":["2017YFC1307600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1098-8","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T09:30:16Z","timestamp":1540459816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Value of reduced glomerular filtration rate assessment with cardiometabolic index: insights from a population-based Chinese cohort"],"prefix":"10.1186","volume":"19","author":[{"given":"Hao-Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Rui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Xian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"1098_CR1","doi-asserted-by":"crossref","unstructured":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117\u201371.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"1098_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815\u201322.","journal-title":"Lancet"},{"key":"1098_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.ackd.2014.09.004","volume":"22","author":"B Horowitz","year":"2015","unstructured":"Horowitz B, Miskulin D, Zager P. Epidemiology of hypertension in CKD. Adv Chronic Kidney Dis. 2015;22:88\u201395.","journal-title":"Adv Chronic Kidney Dis"},{"key":"1098_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ki.2010.115","volume":"78","author":"A Levey","year":"2010","unstructured":"Levey A, Astor B, Stevens L, Coresh J. Chronic kidney disease, diabetes, and hypertension: what's in a name? Kidney Int. 2010;78:19\u201322.","journal-title":"Kidney Int"},{"key":"1098_CR5","doi-asserted-by":"publisher","first-page":"c269","DOI":"10.1159\/000321382","volume":"118","author":"R Nugent","year":"2011","unstructured":"Nugent R, Fathima S, Feigl A, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118:c269\u201377.","journal-title":"Nephron Clin Pract"},{"key":"1098_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2471\/BLT.17.206441","volume":"96","author":"V Luyckx","year":"2018","unstructured":"Luyckx V, Tonelli M, Stanifer J. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96:414\u201322D.","journal-title":"Bull World Health Organ"},{"key":"1098_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11154-016-9402-z","volume":"18","author":"M Hager","year":"2017","unstructured":"Hager M, Narla A, Tannock L. Dyslipidemia in patients with chronic kidney disease. Rev Endocr Metab Disord. 2017;18:29\u201340.","journal-title":"Rev Endocr Metab Disord"},{"key":"1098_CR8","first-page":"iv105","volume":"28","author":"F Mallamaci","year":"2013","unstructured":"Mallamaci F, Tripepi G. Obesity and CKD progression: hard facts on fat CKD patients. Nephrol Dial Transplant. 2013;28:iv105\u2013iv8.","journal-title":"Nephrol Dial Transplant"},{"key":"1098_CR9","doi-asserted-by":"publisher","first-page":"e106778","DOI":"10.1371\/journal.pone.0106778","volume":"9","author":"X Hou","year":"2014","unstructured":"Hou X, Wang C, Zhang X, Zhao X, Wang Y, Li C, et al. Triglyceride levels are closely associated with mild declines in estimated glomerular filtration rates in middle-aged and elderly Chinese with normal serum lipid levels. PLoS One. 2014;9:e106778.","journal-title":"PLoS One"},{"key":"1098_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2014.12.013","volume":"238","author":"M Shimizu","year":"2015","unstructured":"Shimizu M, Furusyo N, Mitsumoto F, Takayama K, Ura K, Hiramine S, et al. Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa population study (KOPS). Atherosclerosis. 2015;238:207\u201312.","journal-title":"Atherosclerosis"},{"key":"1098_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/MAJ.0b013e3181a92804","volume":"338","author":"P Lee","year":"2009","unstructured":"Lee P, Chang H, Tung C, Hsu Y, Lei C, Chang H, et al. Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults. Am J Med Sci. 2009;338:185\u20139.","journal-title":"Am J Med Sci"},{"key":"1098_CR12","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1053\/j.ajkd.2015.05.011","volume":"66","author":"K Tsuruya","year":"2015","unstructured":"Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, et al. Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal study in a large Japanese population. Am J Kidney Dis. 2015;66:972\u201383.","journal-title":"Am J Kidney Dis"},{"key":"1098_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.clnu.2014.09.007","volume":"34","author":"C Ho","year":"2015","unstructured":"Ho C, Chen J, Chen S, Tsai Y, Weng Y, Tsao Y, et al. Relationship between TG\/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population. Clin Nutr. 2015;34:874\u201380.","journal-title":"Clin Nutr"},{"key":"1098_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1159\/000485861","volume":"42","author":"J Wen","year":"2017","unstructured":"Wen J, Chen Y, Huang Y, Lu Y, Liu X, Zhou H, et al. Association of the TG\/HDL-C and non-HDL-C\/HDL-C ratios with chronic kidney disease in an adult Chinese population. Kidney Blood Press Res. 2017;42:1141\u201354.","journal-title":"Kidney Blood Press Res"},{"key":"1098_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1053\/j.ajkd.2005.06.007","volume":"46","author":"H Kramer","year":"2005","unstructured":"Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the hypertension detection and follow-up program. Am J Kidney Dis. 2005;46:587\u201394.","journal-title":"Am J Kidney Dis"},{"key":"1098_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.291.7.844","volume":"291","author":"C Fox","year":"2004","unstructured":"Fox C, Larson M, Leip E, Culleton B, Wilson P, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844\u201350.","journal-title":"JAMA"},{"key":"1098_CR17","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1681\/ASN.2005060638","volume":"17","author":"E Ejerblad","year":"2006","unstructured":"Ejerblad E, Fored C, Lindblad P, Fryzek J, McLaughlin J, Nyr\u00e9n O. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17:1695\u2013702.","journal-title":"J Am Soc Nephrol"},{"key":"1098_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12887-015-0366-z","volume":"15","author":"F Bacopoulou","year":"2015","unstructured":"Bacopoulou F, Efthymiou V, Landis G, Rentoumis A, Chrousos G. Waist circumference, waist-to-hip ratio and waist-to-height ratio reference percentiles for abdominal obesity among Greek adolescents. BMC Pediatr. 2015;15:50.","journal-title":"BMC Pediatr"},{"key":"1098_CR19","doi-asserted-by":"publisher","first-page":"e3769","DOI":"10.1097\/MD.0000000000003769","volume":"95","author":"Y He","year":"2016","unstructured":"He Y, Li F, Wang F, Ma X, Zhao X, Zeng Q. The association of chronic kidney disease and waist circumference and waist-to-height ratio in Chinese urban adults. Medicine (Baltimore). 2016;95:e3769.","journal-title":"Medicine (Baltimore)"},{"key":"1098_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.nut.2007.08.007","volume":"23","author":"C-H Lin","year":"2007","unstructured":"Lin C-H, Chou C-Y, Lin C-C, Huang C-C, Liu C-S, Lai S-W. Waist-to-height ratio is the best index of obesity in association with chronic kidney disease. Nutrition. 2007;23:788\u201393.","journal-title":"Nutrition"},{"key":"1098_CR21","doi-asserted-by":"publisher","first-page":"e88873","DOI":"10.1371\/journal.pone.0088873","volume":"9","author":"K Odagiri","year":"2014","unstructured":"Odagiri K, Mizuta I, Yamamoto M, Miyazaki Y, Watanabe H, Uehara A. Waist to height ratio is an independent predictor for the incidence of chronic kidney disease. PLoS One. 2014;9:e88873.","journal-title":"PLoS One"},{"key":"1098_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12882-018-0837-1","volume":"19","author":"Y Dong","year":"2018","unstructured":"Dong Y, Wang Z, Chen Z, Wang X, Zhang L, Nie J, et al. Comparison of visceral, body fat indices and anthropometric measures in relation to chronic kidney disease among Chinese adults from a large scale cross-sectional study. BMC Nephrol. 2018;19:40.","journal-title":"BMC Nephrol"},{"key":"1098_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2215\/CJN.07010716","volume":"12","author":"M Madero","year":"2017","unstructured":"Madero M, Katz R, Murphy R, Newman A, Patel K, Ix J, et al. Comparison between different measures of body fat with kidney function decline and incident CKD. Clin J Am Soc Nephrol. 2017;12:893\u2013903.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1098_CR24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/ATVBAHA.107.159228","volume":"28","author":"J Despr\u00e9s","year":"2008","unstructured":"Despr\u00e9s J, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039\u201349.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1098_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cca.2014.08.042","volume":"438","author":"I Wakabayashi","year":"2015","unstructured":"Wakabayashi I, Daimon T. The \"cardiometabolic index\" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274\u20138.","journal-title":"Clin Chim Acta"},{"key":"1098_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/00325481.2018.1444901","volume":"130","author":"H Wang","year":"2018","unstructured":"Wang H, Chen Y, Sun G, Jia P, Qian H, Sun Y. Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population. Postgrad Med. 2018;130:325\u201333.","journal-title":"Postgrad Med"},{"key":"1098_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12872-018-0798-0","volume":"18","author":"H Wang","year":"2018","unstructured":"Wang H, Sun Y, Li Z, Guo X, Chen S, Ye N, et al. Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China. BMC Cardiovasc Disord. 2018;18:62.","journal-title":"BMC Cardiovasc Disord"},{"key":"1098_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/00325481.2017.1375714","volume":"129","author":"H Wang","year":"2017","unstructured":"Wang H, Chen Y, Guo X, Chang Y, Sun Y. Usefulness of cardiometabolic index for the estimation of ischemic stroke risk among general population in rural China. Postgrad Med. 2017;129:834\u201341.","journal-title":"Postgrad Med"},{"key":"1098_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.kjms.2016.10.003","volume":"32","author":"M Dursun","year":"2016","unstructured":"Dursun M, Besiroglu H, Otunctemur A, Ozbek E. Association between cardiometabolic index and erectile dysfunction: a new index for predicting cardiovascular disease. Kaohsiung J Med Sci. 2016;32:620\u20133.","journal-title":"Kaohsiung J Med Sci"},{"key":"1098_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jash.2015.02.014","volume":"9","author":"Z Li","year":"2015","unstructured":"Li Z, Guo X, Zheng L, Yang H, Sun Y. Grim status of hypertension in rural China: results from Northeast China rural cardiovascular health study 2013. J Am Soc Hypertens. 2015;9:358\u201364.","journal-title":"J Am Soc Hypertens"},{"key":"1098_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/07853890.2018.1445277","volume":"50","author":"H Wang","year":"2018","unstructured":"Wang H, Li Z, Guo X, Chen Y, Chen S, Tian Y, et al. Contribution of non-traditional lipid profiles to reduced glomerular filtration rate in H-type hypertension population of rural China. Ann Med. 2018;50:249\u201359.","journal-title":"Ann Med"},{"key":"1098_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/00325481.2017.1255126","volume":"129","author":"S Chen","year":"2017","unstructured":"Chen S, Guo X, Dong S, Li Z, Sun Y. Relationship between lifestyle factors and hyperhomocysteinemia in general Chinese population: a cross-sectional study. Postgrad Med. 2017;129:216\u201323.","journal-title":"Postgrad Med"},{"key":"1098_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"H Kahn","year":"2005","unstructured":"Kahn H. The \"lipid accumulation product\" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26.","journal-title":"BMC Cardiovasc Disord"},{"key":"1098_CR34","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"M Amato","year":"2010","unstructured":"Amato M, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33:920\u20132.","journal-title":"Diabetes Care"},{"key":"1098_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"A Levey","year":"2009","unstructured":"Levey A, Stevens L, Schmid C, Zhang Y, Castro A, Feldman H, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"1098_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"P Stevens","year":"2013","unstructured":"Stevens P, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825\u201330.","journal-title":"Ann Intern Med"},{"key":"1098_CR37","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"A Chobanian","year":"2003","unstructured":"Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, et al. The seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560\u201372.","journal-title":"JAMA"},{"key":"1098_CR38","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"2. Classification and Diagnosis of Diabetes","year":"2018","unstructured":"2. Classification and Diagnosis of Diabetes. Diabetes Care. 2018;41:S13\u201327.","journal-title":"Diabetes Care"},{"key":"1098_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.21037\/atm.2016.02.11","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang Z. Univariate description and bivariate statistical inference: the first step delving into data. Ann Transl Med. 2016;4:91.","journal-title":"Ann Transl Med"},{"key":"1098_CR40","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1046\/j.1523-1755.2002.00626.x","volume":"62","author":"M Tozawa","year":"2002","unstructured":"Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 2002;62:1743\u20139.","journal-title":"Kidney Int"},{"key":"1098_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2017.05.013","volume":"122","author":"G Seravalle","year":"2017","unstructured":"Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017;122:1\u20137.","journal-title":"Pharmacol Res"},{"key":"1098_CR42","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"R DeFronzo","year":"2015","unstructured":"DeFronzo R, Ferrannini E, Groop L, Henry R, Herman W, Holst J, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019.","journal-title":"Nat Rev Dis Primers"},{"key":"1098_CR43","doi-asserted-by":"crossref","unstructured":"Yun HR, Kim H, Park JT, Chang TI, Yoo TH, Kang SW, et al. Am J Kidney Dis. 2018;72(3):400-10.","DOI":"10.1053\/j.ajkd.2018.02.362"},{"key":"1098_CR44","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1161\/CIRCULATIONAHA.111.077602","volume":"124","author":"K Britton","year":"2011","unstructured":"Britton K, Fox C. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124:e837\u201341.","journal-title":"Circulation"},{"key":"1098_CR45","doi-asserted-by":"crossref","unstructured":"Dai D, Chang Y, Chen Y, Chen S, Yu S, Guo X, et al. Int J Environ Res Public Health. 2016;13(12).","DOI":"10.3390\/ijerph13121231"},{"key":"1098_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/j.jrn.2017.07.006","volume":"28","author":"Y Chen","year":"2018","unstructured":"Chen Y, Lai S, Tsai Y, Chang S. Visceral adiposity index as a predictor of chronic kidney disease in a relatively healthy population in Taiwan. J Ren Nutr. 2018;28:91\u2013100.","journal-title":"J Ren Nutr"},{"key":"1098_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1053\/j.ajkd.2015.08.027","volume":"67","author":"C Garofalo","year":"2016","unstructured":"Garofalo C, Borrelli S, Pacilio M, Minutolo R, Chiodini P, De Nicola L, et al. Hypertension and prehypertension and prediction of development of decreased estimated GFR in the general population: a meta-analysis of cohort studies. Am J Kidney Dis. 2016;67:89\u201397.","journal-title":"Am J Kidney Dis"},{"key":"1098_CR48","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1097\/HJH.0b013e32833d95fe","volume":"28","author":"C Tsioufis","year":"2010","unstructured":"Tsioufis C, Kokkinos P, Macmanus C, Thomopoulos C, Faselis C, Doumas M, et al. Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk. J Hypertens. 2010;28:2299\u2013308.","journal-title":"J Hypertens"},{"key":"1098_CR49","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/ndt\/gfv009","volume":"30","author":"P Masson","year":"2015","unstructured":"Masson P, Webster A, Hong M, Turner R, Lindley R, Craig J. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30:1162\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 13","key":"1098_CR50","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1093\/joneph\/21.S13.S113","volume":"21","author":"G Bellinghieri","year":"2008","unstructured":"Bellinghieri G, Santoro D, Mallamace A, Savica V. Sexual dysfunction in chronic renal failure. J Nephrol. 2008;21(Suppl 13):S113\u20137.","journal-title":"J Nephrol"},{"key":"1098_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.pcad.2018.07.001","volume":"61","author":"N Naderi","year":"2018","unstructured":"Naderi N, Kleine C, Park C, Hsiung J, Soohoo M, Tantisattamo E, et al. Obesity paradox in advanced kidney disease: from bedside to the bench. Prog Cardiovasc Dis. 2018;61:168\u201381.","journal-title":"Prog Cardiovasc Dis"},{"key":"1098_CR52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.pcad.2013.10.005","volume":"56","author":"J Park","year":"2014","unstructured":"Park J, Ahmadi SF, Streja E, Molnar MZ, Flegal KM, Gillen D, et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis. 2014;56:415\u201325.","journal-title":"Prog Cardiovasc Dis"},{"key":"1098_CR53","first-page":"E971","volume":"277","author":"V Mohamed-Ali","year":"1999","unstructured":"Mohamed-Ali V, Goodrick S, Bulmer K, Holly J, Yudkin J, Coppack S. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Phys. 1999;277:E971\u20135.","journal-title":"Am J Phys"},{"key":"1098_CR54","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1681\/ASN.2015101116","volume":"27","author":"C Drechsler","year":"2016","unstructured":"Drechsler C, Wanner C. The obesity paradox and the role of inflammation. J Am Soc Nephrol. 2016;27:1270\u20132.","journal-title":"J Am Soc Nephrol"},{"key":"1098_CR55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0021-9258(18)66012-0","volume":"215","author":"E KORN","year":"1955","unstructured":"KORN E. Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J Biol Chem. 1955;215:15\u201326.","journal-title":"J Biol Chem"},{"key":"1098_CR56","first-page":"F925","volume":"273","author":"N Vaziri","year":"1997","unstructured":"Vaziri N, Wang X, Liang K. Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure. Am J Phys. 1997;273:F925\u201330.","journal-title":"Am J Phys"},{"key":"1098_CR57","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/ki.1996.515","volume":"50","author":"N Vaziri","year":"1996","unstructured":"Vaziri N, Liang K. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int. 1996;50:1928\u201335.","journal-title":"Kidney Int"},{"key":"1098_CR58","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/ndt\/14.6.1462","volume":"14","author":"N Vaziri","year":"1999","unstructured":"Vaziri N, Deng G, Liang K. Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure. Nephrol Dial Transplant. 1999;14:1462\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"1098_CR59","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1046\/j.1523-1755.2001.00734.x","volume":"59","author":"N Vaziri","year":"2001","unstructured":"Vaziri N, Liang K, Parks J. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure. Kidney Int. 2001;59:2192\u20136.","journal-title":"Kidney Int"},{"key":"1098_CR60","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00109-005-0030-4","volume":"84","author":"V Zannis","year":"2006","unstructured":"Zannis V, Chroni A, Krieger M. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med. 2006;84:276\u201394.","journal-title":"J Mol Med"},{"key":"1098_CR61","doi-asserted-by":"publisher","first-page":"F1203","DOI":"10.1152\/ajprenal.00468.2010","volume":"300","author":"L Ma","year":"2011","unstructured":"Ma L, Corsa B, Zhou J, Yang H, Li H, Tang Y, et al. Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am J Physiol Renal Physiol. 2011;300:F1203\u2013113.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1098_CR62","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/ndt\/gft094","volume":"28","author":"B Spoto","year":"2013","unstructured":"Spoto B, Zoccali C. Spleen IL-10, a key player in obesity-driven renal risk. Nephrol Dial Transplant. 2013;28:1061\u20134.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1098-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:45:04Z","timestamp":1775252704000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1098-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1098-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"23 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in compliance with the ethical principle of the Declaration of Helsinki. Written informed consents were acquired from all participants and all procedures were performed in accordance with the ethical standards. The Ethics Committee of China Medical University (Shenyang, China) approved the study protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"294"}}